STOCK TITAN

[144] Solid Biosciences Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Kevin Tan has filed a notice to sell SLDB common stock under Rule 144. The planned sale covers 26,837 shares of common stock through E*TRADE Financial, with an aggregate market value of $172,747.09, to be sold on or about February 2, 2026 on NASDAQ.

These shares were acquired on February 2, 2026 via settlement of performance shares as compensation from the issuer. In the previous three months, Kevin Tan also sold 5,704 shares of common stock on January 13, 2026, generating gross proceeds of $30,060.08. Shares outstanding were 82,561,235 at the time listed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Solid Bioscience

NASDAQ:SLDB

View SLDB Stock Overview

SLDB Rankings

SLDB Latest News

SLDB Latest SEC Filings

SLDB Stock Data

736.95M
65.05M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CHARLESTOWN